Crosstalk between endoplasmic reticulum stress and oxidative stress in the progression of diabetic nephropathy.
Adult
Biomarkers
/ metabolism
Diabetes Mellitus, Type 2
/ metabolism
Diabetic Nephropathies
/ metabolism
Endoplasmic Reticulum Stress
Female
Humans
Male
Membrane Glycoproteins
/ metabolism
Middle Aged
Oxidative Stress
Oxidoreductases
/ metabolism
Protein Disulfide-Isomerases
/ metabolism
THP-1 Cells
Crosstalk
Diabetic nephropathy
ER oxidase 1α
Endoplasmic reticulum stress
Oxidative stress
Protein disulfide isomerase
Journal
Cell stress & chaperones
ISSN: 1466-1268
Titre abrégé: Cell Stress Chaperones
Pays: Netherlands
ID NLM: 9610925
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
received:
05
06
2020
accepted:
23
10
2020
revised:
20
10
2020
pubmed:
9
11
2020
medline:
15
12
2021
entrez:
8
11
2020
Statut:
ppublish
Résumé
Increasing evidence in substantiating the roles of endoplasmic reticulum stress, oxidative stress, and inflammatory responses and their interplay is evident in various diseases. However, an in-depth mechanistic understanding of the crosstalk between the intracellular stress signaling pathways and inflammatory responses and their participation in disease progression has not yet been explored. Progress has been made in our understanding of the cross talk and integrated stress signaling network between endoplasmic reticulum stress and oxidative stress towards the pathogenesis of diabetic nephropathy. In this present study, we studied the crosstalk between the endoplasmic reticulum stress and oxidative stress by understanding the role of protein disulfide isomerase and endoplasmic reticulum oxidase 1α, a key player in redox protein folding in the endoplasmic reticulum. We had recruited a total of 90 subjects and divided into three groups (control (n = 30), type 2 diabetes mellitus (n = 30), and diabetic nephropathy (n = 30)). We found that endoplasmic reticulum stress markers, activating transcription factor 6, inositol-requiring enzyme 1α, protein kinase RNA-like endoplasmic reticulum kinase, C/EBP homologous protein, and glucose-regulated protein-78; oxidative stress markers, thioredoxin-interacting protein and cytochrome b-245 light chain; and the crosstalk markers, protein disulfide isomerase and endoplasmic reticulum oxidase-1α, were progressively elevated in type 2 diabetes mellitus and diabetic nephropathy subjects. The association between the crosstalk markers showed a positive correlation with endoplasmic reticulum stress and oxidative stress markers. Further, the interplay between endoplasmic reticulum stress and oxidative stress was investigated in vitro using a human leukemic monocytic cell line under a hyperglycemic environment and examined the expression of protein disulfide isomerase and endoplasmic reticulum oxidase-1α. DCFH-DA assay and flow cytometry were performed to detect the production of free radicals. Further, phosphorylation of eIF2α in high glucose-exposed cells was studied using western blot. In conclusion, our results shed light on the crosstalk between endoplasmic reticulum stress and oxidative stress and significantly contribute to the onset and progression of diabetic nephropathy and therefore represent the major therapeutic targets for alleviating micro- and macrovascular complications associated with this metabolic disturbance. Graphical abstract.
Identifiants
pubmed: 33161510
doi: 10.1007/s12192-020-01176-z
pii: 10.1007/s12192-020-01176-z
pmc: PMC7925747
doi:
Substances chimiques
Biomarkers
0
Membrane Glycoproteins
0
ERO1A protein, human
EC 1.-
Oxidoreductases
EC 1.-
PDIA2 protein, human
EC 5.3.4.1
Protein Disulfide-Isomerases
EC 5.3.4.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
311-321Références
Sci Rep. 2018 Mar 23;8(1):5126
pubmed: 29572460
Science. 2000 Jan 28;287(5453):664-6
pubmed: 10650002
J Cell Biol. 2004 Feb 2;164(3):341-6
pubmed: 14757749
Cancer Res. 2006 Oct 15;66(20):9895-902
pubmed: 17047051
Cell. 2001 Mar 23;104(6):937-48
pubmed: 11290330
Chin Med J (Engl). 2019 Apr 5;132(7):868-872
pubmed: 30829719
Front Plant Sci. 2019 Jun 12;10:749
pubmed: 31249578
Diabetes Metab Syndr. 2019 Jan - Feb;13(1):734-737
pubmed: 30641797
Curr Mol Med. 2016;16(6):533-44
pubmed: 27211800
Trends Endocrinol Metab. 2012 Aug;23(8):381-90
pubmed: 22770719
Nat Cell Biol. 1999 Jul;1(3):130-5
pubmed: 10559898
Nat Rev Endocrinol. 2011 Mar;7(3):176-84
pubmed: 21151200
Cell Metab. 2009 Jul;10(1):13-26
pubmed: 19583950
Free Radic Res. 2015 Mar;49(3):244-52
pubmed: 25511473
Med Sci Monit. 2010 Feb;16(2):RA37-48
pubmed: 20110930
Front Cell Dev Biol. 2015 May 21;3:30
pubmed: 26052512
Semin Immunopathol. 2013 May;35(3):333-50
pubmed: 23529219
Biochem Biophys Res Commun. 2005 Sep 2;334(3):787-95
pubmed: 16023999
Oncol Rep. 2011 Jul;26(1):185-91
pubmed: 21503584
Oncogene. 2008 Oct 27;27(50):6407-18
pubmed: 18955969
Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2653-8
pubmed: 16477035
Cell Death Dis. 2015 Jan 15;6:e1591
pubmed: 25590801
Cell Metab. 2008 Jun;7(6):520-32
pubmed: 18522833
J Nutr Biochem. 2018 May;55:142-156
pubmed: 29455095
Methods Mol Biol. 2002;196:99-103
pubmed: 12152222
Diabetes. 1983 May;32 Suppl 2:64-78
pubmed: 6400670
Int J Med Sci. 2014 Sep 06;11(11):1185-200
pubmed: 25249787
Int J Mol Med. 2017 Dec;40(6):1957-1964
pubmed: 29039478
J Leukoc Biol. 2011 Oct;90(4):799-810
pubmed: 21791598
Biochem J. 2010 May 13;428(2):183-90
pubmed: 20331437
Diabetes. 2003 May;52(5):1256-64
pubmed: 12716761
Antioxid Redox Signal. 2003 Aug;5(4):381-7
pubmed: 13678525
Cell Death Dis. 2018 Feb 28;9(3):329
pubmed: 29491386
Br J Pharmacol. 2015 May;172(10):2557-72
pubmed: 25586174
J Cell Biol. 2001 May 28;153(5):1011-22
pubmed: 11381086
Nat Rev Drug Discov. 2011 Jun;10(6):453-71
pubmed: 21629295
Nat Rev Nephrol. 2017 Nov;13(11):681-696
pubmed: 28970584
Cold Spring Harb Perspect Biol. 2019 Aug 1;11(8):
pubmed: 30670468
Exp Diabetes Res. 2012;2012:481840
pubmed: 22474423
Biochim Biophys Acta Mol Cell Res. 2019 Apr;1866(4):713-726
pubmed: 30528975
Antioxid Redox Signal. 2006 Sep-Oct;8(9-10):1391-418
pubmed: 16986999
PLoS One. 2013;8(3):e59610
pubmed: 23555724